Affordable Access

[Short-term tolerance of three days pulse methyprednisolone therapy: a prospective study in 146 patients].

Authors
Type
Published Article
Journal
La Revue de Médecine Interne
0248-8663
Publisher
Elsevier
Publication Date
Volume
26
Issue
1
Pages
20–26
Identifiers
PMID: 15639322
Source
Medline
License
Unknown

Abstract

Severe complications of pulse methylprednisolone, mainly cardiovascular, are strongly related to underlying comorbidities. Glucose monitoring is necessary only in diabetic patients. Potassium movements suggest a risk of hypokalicystia, of potential danger in patients with cardiac disease. A close clinical, blood pressure and electrocardiographic monitoring is needed during the whole treatment.

Statistics

Seen <100 times